NYSE:BMR - Biomed Realty Trust Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $23.81 0.00 (0.00 %) (As of 07/22/2018 08:59 AM ET)Previous Close$23.81Today's Range$23.81 - $23.8152-Week Range$17.94 - $25.08VolumeN/AAverage Volume7.19 million shsMarket CapitalizationN/AP/E RatioN/ADividend Yield4.38%BetaN/A Company ProfileFinancialsDividend HistoryEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email BioMed Realty Trust, Inc. operates as a real estate investment trust (REIT). The Company is the parent company and general partner of BioMed Realty, L.P. The Company owns, acquires, develops, redevelops, leases and manages laboratory and office space for the life science industry. The Company's tenants primarily include biotechnology and pharmaceutical companies, scientific research institutions, government agencies and other entities involved in the life science industry. The Company's properties are located in markets, which has centers for scientific research, including Boston, San Francisco, San Diego, Maryland, New York, New Jersey, Pennsylvania, North Carolina, Seattle, Cambridge (the United Kingdom) and research parks located near or adjacent to universities and their related medical systems. The Company owns interests in properties comprising approximately 17.5 million rentable square feet. Receive BMR News and Ratings via Email Sign-up to receive the latest news and ratings for BMR and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NYSE Industry N/A Sub-IndustryOffice REITs SectorN/A SymbolNYSE:BMR CUSIP09063H10 Webwww.biomedrealty.com Phone+1-858-4859840 Debt Debt-to-Equity RatioN/A Current RatioN/A Quick RatioN/A Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual SalesN/A Price / SalesN/A Cash FlowN/A Price / CashN/A Book ValueN/A Price / BookN/A Profitability EPS (Most Recent Fiscal Year)N/A Net IncomeN/A Net Margins18.98% Return on Equity3.73% Return on Assets2.07% Miscellaneous EmployeesN/A Outstanding Shares203,530,000Market Cap$0.00 Biomed Realty Trust (NYSE:BMR) Frequently Asked Questions What is Biomed Realty Trust's stock symbol? Biomed Realty Trust trades on the New York Stock Exchange (NYSE) under the ticker symbol "BMR." How were Biomed Realty Trust's earnings last quarter? Biomed Realty Trust Inc (NYSE:BMR) announced its earnings results on Tuesday, April, 28th. The real estate investment trust reported $0.41 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $0.37 by $0.04. The real estate investment trust earned $178.01 million during the quarter, compared to analyst estimates of $167.08 million. Biomed Realty Trust had a return on equity of 3.73% and a net margin of 18.98%. The company's revenue for the quarter was up 5.4% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.38 earnings per share. View Biomed Realty Trust's Earnings History. What is the consensus analysts' recommendation for Biomed Realty Trust? 0 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Biomed Realty Trust in the last year. There are currently for the stock, resulting in a consensus recommendation of "N/A." Who are Biomed Realty Trust's key executives? Biomed Realty Trust's management team includes the folowing people: Greg N. Lubushkin, Chief Financial Officer (Age 62)James R. Berens, President of Wexford Science & Technology (Age 61)Jonathan Paul Klassen, Executive Vice President, General Counsel, Secretary (Age 39)John P. Bonanno, Executive Vice President, Leasing & Development (Age 49)Karen A. Sztraicher, Executive Vice President - Asset Management (Age 51) Has Biomed Realty Trust been receiving favorable news coverage? News headlines about BMR stock have been trending somewhat positive this week, according to Accern Sentiment. The research firm rates the sentiment of media coverage by reviewing more than 20 million news and blog sources in real-time. Accern ranks coverage of companies on a scale of negative one to one, with scores nearest to one being the most favorable. Biomed Realty Trust earned a coverage optimism score of 0.01 on Accern's scale. They also assigned news coverage about the real estate investment trust an impact score of 45.92 out of 100, indicating that recent media coverage is somewhat unlikely to have an impact on the company's share price in the near future. How do I buy shares of Biomed Realty Trust? Shares of BMR can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Biomed Realty Trust's stock price today? One share of BMR stock can currently be purchased for approximately $23.81. How can I contact Biomed Realty Trust? Biomed Realty Trust's mailing address is 17190 Bernardo Center Dr, SAN DIEGO, CA 92128-7030, United States. The real estate investment trust can be reached via phone at +1-858-4859840. MarketBeat Community Rating for Biomed Realty Trust (NYSE BMR)Community Ranking: 2.4 out of 5 ( )Outperform Votes: 178 (Vote Outperform)Underperform Votes: 199 (Vote Underperform)Total Votes: 377MarketBeat's community ratings are surveys of what our community members think about Biomed Realty Trust and other stocks. Vote "Outperform" if you believe BMR will outperform the S&P 500 over the long term. Vote "Underperform" if you believe BMR will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/22/2018 by MarketBeat.com StaffFeatured Article: What does relative strength index mean?